InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by PRYGOCKI MARK A SR, Director. Officer active across 1 company, notably Clarus Therapeutics Holdings, Inc.. Cumulatively, 3 disclosures have been recorded. Activity tracked since 12 December 2021. The latest transaction was filed on 7 June 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
1,922 shares0Common StockSEC:0000899243-22-021761:0
3,844 shares0Common StockSEC:0000899243-21-048213:0
3,844 shares0Common StockSEC:0000899243-21-048213
3 of 3 declarations
About PRYGOCKI MARK A SR
Mark A. Prygocki Sr is a Director at Clarus Therapeutics Holdings, Inc. In this role, he participates in the governance of the company, which specializes in developing medical treatments. Prygocki brings his expertise in corporate strategy, contributing to the direction and growth of Clarus Therapeutics.
